👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Sartorius AG VZO O.N. (1SRT3)

Milan
Currency in EUR
244.40
+2.80(+1.16%)
Closed
1SRT3 Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
Fair Value
Day's Range
244.40244.40
52 wk Range
205.90381.20
Prev. Close
241.6
Open
244.4
Day's Range
244.4-244.4
52 wk Range
205.9-381.2
Volume
10
Average Volume (3m)
62
1-Year Change
-
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
1SRT3 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
263.21
Upside
+10.55%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period
Show more

Sartorius AG VZO O.N. Company Profile

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Employees
15942
Market
Germany

Compare 1SRT3 to Peers and Sector

Metrics to compare
1SRT3
Peers
Sector
Relationship
P/E Ratio
0.0x26.3x−0.6x
PEG Ratio
0.00−0.640.00
Price/Book
0.0x2.8x2.6x
Price / LTM Sales
0.0x5.0x3.2x
Upside (Analyst Target)
0.0%24.0%47.1%
Fair Value Upside
Unlock−10.8%7.1%Unlock

People Also Watch

40.550
QIA
+0.77%
121.875
SY1G
+0.81%
64.850
BNRGn
-0.20%
511.30
MUVGn
+1.25%

FAQ

What Is the Sartorius AG VZO (1SRT3) Stock Price Today?

The Sartorius AG VZO stock price today is 244.40

What Stock Exchange Does Sartorius AG VZO Trade On?

Sartorius AG VZO is listed and trades on the Milan stock exchange.

What Is the Stock Symbol for Sartorius AG VZO?

The stock symbol for Sartorius AG VZO is "1SRT3."

Does Sartorius AG VZO Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.31%.

What Is the Sartorius AG VZO Market Cap?

As of today, Sartorius AG VZO market cap is 13.21B.

What is Sartorius AG VZO Earnings Per Share?

The Sartorius AG VZO EPS is 1.13.

What Is the Next Sartorius AG VZO Earnings Date?

Sartorius AG VZO will release its next earnings report on 16 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.